The Wegovy & Mounjaro Rebound: Why 90% Regain Weight (And How to Be the 10%)
2026.03.02 - [건강정보] - 위고비·마운자로 중단 후 요요, '이것' 모르면 90% 확률로 다시 찐다
위고비·마운자로 중단 후 요요, '이것' 모르면 90% 확률로 다시 찐다
위고비와 마운자로. '기적의 다이어트 약'이라 불리며 꿈의 체중을 선물해 주었지만, 진짜 승부는 약을 끊는 순간부터 시작됩니다.임상 데이터에 따르면, 약물 중단 후 1년 이내에 감량한 체중의
insightbrilliant.tistory.com
Wegovy and Mounjaro have been hailed as "miracle weight-loss drugs," delivering dream-like transformations. However, the real battle doesn’t begin until the moment you stop the injections.
Clinical data suggests a sobering reality: most patients are highly likely to regain more than two-thirds of their lost weight within a year of discontinuation. Why do some maintain their progress while 90% fall back? Let’s dive into the logic behind the "Yo-Yo" effect and the one secret to stopping it.
1. Why the 90% Fail: The Biological Backlash
Our bodies are inherently conservative systems that despise change. When you force weight down with medication, your brain perceives it as a "state of emergency."
- The Hormone Betrayal: Once the drug is gone, Ghrelin (the hunger hormone) surges, while Leptin (the fullness hormone) plummets. Your body practically screams for you to eat.
- Metabolic Adaptation: To conserve energy, your body drastically lowers its Basal Metabolic Rate (BMR). You become a "high-efficiency machine" that stores fat even when eating the same amount as before.
2. The One Key to Defeating the Rebound: Muscle & Insulin Sensitivity
The secret lies in preserving muscle mass and maintaining insulin sensitivity.
Most people lose weight on these drugs by simply "not eating." While the scale goes down, your body often burns protein (muscle) for energy before touching fat. When the drug is removed, you’re left with a smaller "engine" (lower muscle mass), causing any incoming calories to be stored immediately as fat.
"Think of muscle as your body’s most expensive engine. If you downsize the engine (muscle) and remove the turbocharger (the drug), the car won't run—it will just collect rust (fat)."
3. A 3-Step Logical Strategy for Long-Term Maintenance
To bring your failure probability down to 0%, follow this science-backed roadmap:
Strategy 1: Obsess Over Body Composition, Not the Scale
High-protein intake is non-negotiable even before you stop the drug. Minimizing muscle loss during the weight-loss phase is the only way to keep your metabolism firing once the medication ends.
Strategy 2: Resistance Training is Survival, Not an Option
Cardio isn't enough. You must perform resistance (weight) training to send a constant signal to your brain: "This muscle is vital; do not burn it!"
Strategy 3: Consider a "Tapering" Phase
Avoid quitting "cold turkey." Consult with a professional to gradually reduce the dosage. This gives your body time to adjust its "Set-point"—the internal weight your brain considers normal.
Final Thought: Insight Trumps Impulse
Wegovy and Mounjaro are sophisticated tools, not permanent cures. Unless you fill the void left by the drug with muscle and a strategic nutritional plan, fighting the laws of nature is nearly impossible. Whether you become a 90% statistic or a 10% success story depends entirely on your logical management.
Keywords: Insulin Resistance, Basal Metabolic Rate (BMR), GLP-1 Maintenance, Wegovy Rebound, Mounjaro Yo-Yo
2026.03.05 - [Bio-Pharma & Obesity Research (바이오·비만 연구] - 2026년 비만 치료의 격변: '게임 체인저'들의 정면 승부
2026년 비만 치료의 격변: '게임 체인저'들의 정면 승부
1. 마운자로(Tirzepatide) vs 위고비(Semaglutide): 승자는 누구?최근 발표된 SURMOUNT-5 임상 결과에 따르면, 72주간의 직접 비교(Head-to-Head)에서 마운자로가 위고비를 압도했습니다.감량 수치: 마운자로 투
insightbrilliant.tistory.com